Howe & Rusling Stake in Pfizer (PFE) Decreased by $12.00 Million; Express Scripts Holding Co (ESRX) Shares Rose While Shelter Ins Retirement Plan Trimmed Its Stake by $1.34 Million

Pfizer Inc. (NYSE:PFE) Logo

Howe & Rusling Inc decreased its stake in Pfizer Inc (PFE) by 78.35% based on its latest 2018Q3 regulatory filing with the SEC. Howe & Rusling Inc sold 272,767 shares as the company’s stock rose 5.56% while stock markets declined. The institutional investor held 75,353 shares of the health care company at the end of 2018Q3, valued at $3.32 million, down from 348,120 at the end of the previous reported quarter. Howe & Rusling Inc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $244.51B market cap company. The stock decreased 1.35% or $0.58 during the last trading session, reaching $42.3. About 9.33 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since January 14, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 18/05/2018 – AstraZeneca hit by falling Crestor sales, higher costs; 15/05/2018 – PFIZER INC – RETACRIT IS EXPECTED TO BE AVAILABLE IN U.S. AT A SIGNIFICANT DISCOUNT TO CURRENT WHOLESALER ACQUISITION COST OF EPOGEN AND PROCRIT; 16/05/2018 – NOVARTIS AG NOVN.S CEO SAYS CONTINUES TO BELIEVE KISQUALI IMPORTANT BUT NOT AS LARGE AS ONCE THOUGHT; 11/04/2018 – PFIZER INC PFE.N : BERENBERG RAISES TARGET PRICE TO $37 FROM $36; 07/05/2018 – FDA Grants Priority Review to Genentech’s Cancer Immunotherapy TECENTRIQ (Atezolizumab) for Initial Treatment of People With a Specific Type of Metastatic Lung Cancer; 22/03/2018 – STAT Plus: Pharmalittle: Glaxo leads race to buy Pfizer consumer unit; U.K. saves $113 million a year on biosimilars; 22/05/2018 – Pfizer: Study Finds Prevnar 13 Associated With Reduced Risk of Hospitalization From Certain Pneumonia in Older Adults; 16/05/2018 – Pfizer: To Present Research on Late-Phase Investigational Compounds; 23/03/2018 – GSK pulls out of auction to buy $20bn Pfizer business; 05/03/2018 Japan 2018 Drug Price Revision: Ono Opdivo another 24% cut after 50% price cut ~1yr ago $MRK Keytruda 11% cut $PFE Bavencio 12% cut $AGN Botox 18% cut Chugai Rituxan 26% cut Chugai Herceptin 20% cut

Shelter Ins Retirement Plan decreased its stake in Express Scripts Holding Co (ESRX) by 33.11% based on its latest 2018Q3 regulatory filing with the SEC. Shelter Ins Retirement Plan sold 14,100 shares as the company’s stock rose 6.50% while stock markets declined. The institutional investor held 28,482 shares of the medical and nursing services company at the end of 2018Q3, valued at $2.71M, down from 42,582 at the end of the previous reported quarter. Shelter Ins Retirement Plan who had been investing in Express Scripts Holding Co for a number of months, seems to be less bullish one the $52.04 billion market cap company. The stock decreased 3.62% or $3.47 during the last trading session, reaching $92.33. About 31.61 million shares traded or 532.84% up from the average. Express Scripts Holding Company (NASDAQ:ESRX) has risen 42.43% since January 14, 2018 and is uptrending. It has outperformed by 42.43% the S&P500. Some Historical ESRX News: 23/04/2018 – Cigna: Cigna and Express Scripts on Monday Each Received Request for Additional Information From DOJ on Merger; 29/03/2018 – EXPRESS SCRIPTS RECENT PRICE DROP `EGREGIOUS’: CREDIT SUISSE; 15/05/2018 – ValueAct Exits Microsoft, Express Scripts as It Adds Sallie Mae; 08/03/2018 – Cigna announced it planned to acquire Express Scripts; 08/03/2018 – St. Louis Business: BREAKING: Cigna buying St. Louis County-based Express Scripts for $67 billion; 08/03/2018 – EXPRESS SCRIPTS HOLDING CO – TRANSACTION IS NOT SUBJECT TO A FINANCING CONDITION; 08/03/2018 – The offer represents a premium of nearly 31 percent to Express Scripts’ Wednesday closing price of $73.42; 08/03/2018 – Globe Mail [Reg]: Health insurer Cigna set to buy Express Scripts: report; 01/05/2018 – EXPRESS SCRIPTS TO EASE ACCESS TO COSTLY CHOLESTEROL DRUG; 08/03/2018 – Health insurer Cigna is close to buying Express Scripts: Report

Investors sentiment increased to 0.85 in Q3 2018. Its up 0.07, from 0.78 in 2018Q2. It increased, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Pictet Cie (Europe) owns 35,880 shares. Convergence Inv Prtn Limited Company stated it has 204,597 shares or 1.84% of all its holdings. Stillwater Capital Advsrs Ltd Liability holds 3.44% in Pfizer Inc. (NYSE:PFE) or 375,750 shares. Majedie Asset Mngmt Limited has invested 0.95% in Pfizer Inc. (NYSE:PFE). Foster Dykema Cabot & Company Ma invested in 0.14% or 19,795 shares. Sei Invests Com has 1.43 million shares. Nomura Asset Mgmt Limited owns 1.31 million shares or 0.56% of their US portfolio. Cibc Ww Markets Inc has invested 0.46% in Pfizer Inc. (NYSE:PFE). Cubic Asset Mgmt Ltd Liability Com reported 2% of its portfolio in Pfizer Inc. (NYSE:PFE). 64,072 are owned by Lourd Cap Ltd Llc. Strategic Llc holds 78,434 shares. Wellington Shields Capital Management Ltd Company stated it has 107,777 shares. Moreover, Barr E S And Commerce has 0.06% invested in Pfizer Inc. (NYSE:PFE). Michigan-based Columbia Asset has invested 1.21% in Pfizer Inc. (NYSE:PFE). Cohen Capital Management Inc has 0.69% invested in Pfizer Inc. (NYSE:PFE).

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on January, 29 before the open. They expect $0.64 EPS, up 3.23% or $0.02 from last year’s $0.62 per share. PFE’s profit will be $3.70 billion for 16.52 P/E if the $0.64 EPS becomes a reality. After $0.78 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -17.95% negative EPS growth.

Since July 20, 2018, it had 0 insider purchases, and 2 insider sales for $1.92 million activity. 40,381 shares were sold by SUSMAN SALLY, worth $1.50M on Friday, July 20.

Howe & Rusling Inc, which manages about $798.49M and $598.66 million US Long portfolio, upped its stake in Raytheon Co (NYSE:RTN) by 14,532 shares to 81,233 shares, valued at $16.79 million in 2018Q3, according to the filing. It also increased its holding in Ishares Tr (OEF) by 2,606 shares in the quarter, for a total of 63,636 shares, and has risen its stake in Cvs Health Corp (NYSE:CVS).

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer: Consumer Health Deal Looks Good – Seeking Alpha” on December 20, 2018, also Streetinsider.com with their article: “Pfizer (PFE) Begins Phase 2b/3 Clinical Trial for PF-06651600 for Treatment of Patients with Moderate to Severe Alopecia Areata – StreetInsider.com” published on January 03, 2019, Zacks.com published: “Pfizer (PFE) Stock Moves -1.58%: What You Should Know – Zacks.com” on December 17, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer, Merck cancel avelumab study – Seeking Alpha” published on December 21, 2018 as well as Streetinsider.com‘s news article titled: “Pfizer (PFE) Phase 2b STRIVE Clinical Trial of Staphylococcus aureus Vaccine Discontinued Due to Futility – StreetInsider.com” with publication date: December 20, 2018.

Among 23 analysts covering Pfizer (NYSE:PFE), 8 have Buy rating, 1 Sell and 14 Hold. Therefore 35% are positive. Pfizer had 89 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Wednesday, August 1 by Bank of America. The stock of Pfizer Inc. (NYSE:PFE) earned “Neutral” rating by Credit Suisse on Thursday, July 20. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Jefferies on Thursday, April 7. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, August 2. Credit Suisse maintained it with “Neutral” rating and $39 target in Wednesday, January 31 report. Barclays Capital initiated the shares of PFE in report on Tuesday, December 1 with “Equal-Weight” rating. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) rating on Monday, June 12. BMO Capital Markets has “Hold” rating and $3300 target. The rating was maintained by Jefferies with “Buy” on Tuesday, September 13. BMO Capital Markets maintained the shares of PFE in report on Wednesday, May 2 with “Outperform” rating. The firm has “Hold” rating given on Friday, April 28 by BMO Capital Markets.

Among 25 analysts covering Express Scripts (NASDAQ:ESRX), 6 have Buy rating, 3 Sell and 16 Hold. Therefore 24% are positive. Express Scripts had 73 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by SunTrust with “Buy” on Thursday, December 14. The firm earned “Hold” rating on Thursday, March 8 by Jefferies. As per Tuesday, January 30, the company rating was downgraded by Bernstein. The stock of Express Scripts Holding Company (NASDAQ:ESRX) earned “Outperform” rating by Robert W. Baird on Friday, December 15. The firm has “Sell” rating by Deutsche Bank given on Monday, February 22. On Friday, July 7 the stock rating was maintained by Jefferies with “Buy”. The stock has “Hold” rating by RBC Capital Markets on Thursday, December 14. The firm earned “Market Perform” rating on Monday, March 12 by Bernstein. The firm earned “Overweight” rating on Wednesday, July 27 by Barclays Capital. The stock of Express Scripts Holding Company (NASDAQ:ESRX) earned “Equal-Weight” rating by Barclays Capital on Thursday, November 1.

More notable recent Express Scripts Holding Company (NASDAQ:ESRX) news were published by: Nasdaq.com which released: “Cigna to Take Over Express Scripts (ESRX) for $67 Billion – Nasdaq” on March 12, 2018, also 247Wallst.com with their article: “Top Analyst Upgrades and Downgrades: Altbaba, AutoDesk, AutoZone, CBS, Eli Lilly, Lululemon, Michael’s, Target and More – 24/7 Wall St.” published on December 27, 2018, Seekingalpha.com published: “Scilex’s ZTlido added to Express Scripts national formularies – Seeking Alpha” on January 14, 2019. More interesting news about Express Scripts Holding Company (NASDAQ:ESRX) were released by: Nasdaq.com and their article: “Monday Sector Leaders: Services, Healthcare – Nasdaq” published on December 24, 2018 as well as Nasdaq.com‘s news article titled: “Notable Wednesday Option Activity: PRMW, ESRX, CRM – Nasdaq” with publication date: November 07, 2018.

Investors sentiment decreased to 0.69 in 2018 Q3. Its down 0.09, from 0.78 in 2018Q2. It dived, as 62 investors sold ESRX shares while 398 reduced holdings. 117 funds opened positions while 199 raised stakes. 458.93 million shares or 0.78% less from 462.54 million shares in 2018Q2 were reported. Next Fin Group Inc Incorporated stated it has 0.02% in Express Scripts Holding Company (NASDAQ:ESRX). Hbk Sorce Advisory Ltd Liability Company has 2,832 shares. Parsons Cap Management Ri holds 24,504 shares or 0.25% of its portfolio. Shelton Cap reported 52,866 shares stake. Sun Life Inc reported 1,545 shares. 3.17 million were reported by Schwab Charles Investment Management Inc. Vertex One Asset reported 30,000 shares. Hussman Strategic Advisors invested in 0.02% or 800 shares. Mountain Pacific Advisers Inc Id reported 194 shares. Hayek Kallen Inv Mngmt, Alabama-based fund reported 6,378 shares. Citadel Advisors Ltd Liability Co holds 0% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX) for 29,627 shares. Hedeker Wealth Llc has invested 0.25% in Express Scripts Holding Company (NASDAQ:ESRX). Lowe Brockenbrough And Co Inc has invested 0.11% in Express Scripts Holding Company (NASDAQ:ESRX). York Capital Lc holds 5.46% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX) for 1.82M shares. Boston Ptnrs reported 4,073 shares.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.